New system aims to maximize protection, minimize costs while planning epidemic interventions

A team of researchers has created a software system designed to model epidemics, with the aim of maximizing public-health protections while minimizing economic and social costs.

The coronavirus pandemic has underscored the need to have a well-designed plan to combat epidemics in a way that balances economic health with human safety."

Dennis Shasha, Professor at Courant Institute of Mathematical Sciences, New York University

To address this, Shasha and his colleagues at NYU Abu Dhabi and Ecohealth Alliance, an environmental health nonprofit, developed EpiPolicy ("Epi" is shorthand for "epidemic"), which replicates the extensive "what-if' analysis process that public-health and other professionals undertake in determining a cost-effective policy: a schedule of when, where, and how extensively an intervention, including school closures, social distancing policies, and vaccination drives, should be applied.

EpiPolicy, which may be calibrated to reflect a region's socio-economic and demographic characteristics, simultaneously models each intervention's effect on disease spread and economic cost. Moreover, it captures different scenarios for epidemics like COVID-19.

"The policymaking process is often an iterative and laborious programming-intensive effort where parameters are introduced and refined, model and intervention behaviors are modified, and schedules changed," Shasha observes. "We have designed and developed EpiPolicy to support this effort, but in a way that can potentially simplify the calculations that need to be made under shifting conditions and that is broadly applicable."

Source:
Journal reference:

Tariq, Z., et al. (2021) Planning Epidemic Interventions with EpiPolicy. AGM. doi.org/10.1145/3472749.3474794.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Study explores the emergence and spread of SARS-CoV-2 Delta variant across Brazil